Case study

Italy & Finland: Nexia advises sovereign VC firm on financial and tax due diligence for €19 million investment

Nexia Audirevi (Italy) and Nexia Oy (Finland) advised CDP Ventures SGR SpA for the financial and tax due diligence on Valo Therapeutics Oy.

The client was CDP Venture Capital SGR – Fondo Nazionale Innovazione (National Innovation Fund) – and operates through direct and indirect investment funds, to support start-ups in all stages of their life cycle, with the aim of making the venture capital system a cornerstone of Italy’s economic development and innovation.

CDP Venture Capital SGR supports innovation and brings “doing business” back to the centre of economic development in the most strategic sectors for Italy’s growth.

The client challenge:
Establish a Research & Development ecosystem in southern Italy dedicated to breakthrough cancer therapies.

The solution:
Finance an innovative Finnish start-up Valo Therapeutics Oy and relocate part of R&D operations to Italy. This funding will enable Valo to expand and complete the Phase 1B clinical study of the company’s lead tumour antigen-coated oncolytic virus candidate.

The Nexia Value:
Nexia supported CDP Venture Capital SGR with a multidisciplinary and cross-border team delivering financial and tax due diligence. Nexia Audirevi (Italy) and Nexia Oy (Finland) worked seamlessly together to ensure a smooth and coordinated process.